Riskpilot← Back to searchSign inGet full accessAnnaMed AB
ABActiveOrg 5590689039Kristoffer Huldts Väg 14Business and other management consultancy activities · NACE 7020Est. 20162 employees
Revenue 2024
SEK 2,8M
+10% vs 2023
EBITDA margin
33.4%
+29% vs 2023
Equity ratio
72.9%
Financial strength
Net profit 2024
SEK 684K
-4% vs 2023
| Revenue | SEK 2,8M | +10% |
| EBITDA | SEK 944K | +29% |
| Net profit | SEK 684K | -4% |
| Total assets | SEK 6M | +8% |
| Equity | SEK 4,4M | +18% |
| Employees | 2 | — |
Legal name
AnnaMed AB
Org number
5590689039
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
4 juli 2016
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för företagets verksamhet är att agera konsult inom ekonomi och redovisning samt därmed förenlig verksamhet. Bolaget ska även hyra ut förvärvade bostäder till privata personer eller företag.
Address
Kristoffer Huldts Väg 14
Email
annamed.ab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 90 | 3 614 | 3 247 | 2 667 | 2 672 | 2 559 | 2 826 |
| Staff expenses | — | — | — | — | — | −1 565 | −1 687 | −1 775 |
| EBITDA | 801 | −622 | 1 926 | 1 522 | 1 049 | 1 009 | 731 | 944 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −56 | −56 | −56 |
| EBIT | 801 | −622 | 1 926 | 1 522 | 1 049 | 954 | 676 | 888 |
| Net financials | — | — | — | — | −10 | −45 | −55 | −21 |
| Profit before tax | 601 | −422 | 1 550 | 1 142 | 914 | 1 009 | 908 | 867 |
| Tax | −132 | −0 | −242 | −245 | −190 | −210 | −194 | −183 |
| Net profit | 469 | −422 | 1 308 | 897 | 724 | 798 | 715 | 684 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 806 | 208 | 2 255 | 3 224 | 5 654 | 5 794 | 5 592 | 6 014 |
| Equity | 519 | 97 | 1 405 | 1 902 | 2 426 | 2 984 | 3 699 | 4 382 |
| Long-term debt | 0 | 0 | 0 | 0 | 1 900 | 1 220 | 540 | 460 |
| Short-term debt | 87 | 111 | 474 | 565 | 446 | 608 | 758 | 576 |
| Total debt | 87 | 111 | 474 | 565 | 2 346 | 1 828 | 1 298 | 1 036 |
EBITDA margin
33.4%
This company
15.8%
Market median
+111% vs market
20172024
Equity ratio
72.9%
This company
38.2%
Market median
+91% vs market
20172024
Return on equity
15.6%
This company
18.4%
Market median
+15% vs market
20172024
Net profit margin
24.2%
This company
8.1%
Market median
+199% vs market
20172024
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20172024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20172024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 2022 | — | — | |
BF Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AnnaMed AB 
GerwelMed ABBoard members of AnnaMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nadja Elisabet Kaarina Eriksson | Audit | 0 companies |
| Beatrice Fejde | Audit | 0 companies |
| Anna Dorota Gaska-Dabrowska | Deputy Board Member | 0 companies |
| Agnieszka Grazyna Gerwel | Board of Directors | 0 companies |
| Mateusz Hirsz | Deputy Board Member | 0 companies |
| Anna Halina Szymulska | Chairman | 0 companies |